
Queen of Hearts is now FDA De Novo authorized—and already live across several US health systems. 🇺🇸 Built to go beyond standard ECG criteria, it detects STEMI & STEMI equivalents and directly alerts downstream clinicians to accelerate care.

CEO & Co-Founder at @PowerfulMedical 🫀 | @Forbes 30 under 30 Europe

Queen of Hearts is now FDA De Novo authorized—and already live across several US health systems. 🇺🇸 Built to go beyond standard ECG criteria, it detects STEMI & STEMI equivalents and directly alerts downstream clinicians to accelerate care.



A new era in the rapid diagnosis of STEMI/STEMI equivalents has begun. Rapid diagnosis of ACS that needs immediate, emergent intervention can only be done by the ECG. FDA authorization for the queen of hearts. “deNovo “ means it is the first device of its kind in the world.
🇺🇸 The #FDA has granted De Novo authorization to Queen of Hearts™, our AI ECG model for detecting acute coronary syndrome events, which can include #STEMI and STEMI equivalents and require urgent cardiologist activation. A defining milestone for Powerful Medical. #PMcardio

Swipe for our 2025 review → In 2025, PMcardio helped teams act faster when time matters: • 1,231,997 ECGs analyzed • 124,298 heart attacks detected (including STEMI equivalents) • 9,767 lives prolonged In 2026, our focus is to expand PMcardio to even more physicians.

Congratulations to Powerful Medical for winning the 2025 MedTech Innovator Mid-Stage Grand Prize, earning $200,000 in funding for their impactful AI-driven cardiac diagnostics platform. linkedin.com/company/medtech… linkedin.com/posts/medtech-i… @PMcardioApp

🚨 #AI-based #ECG analysis significantly improved #STEMI detection, reduced false activations, and enhanced recognition of non-conventional presentations. This supports integration of AI-based ECG analysis into acute chest pain pathways. jacc.org/doi/10.1016/j.jcin.… #TCT2025 #JACCINT

True.
Cardiac App of the year = @PMcardioApp Just starting using (thx for rec @drjohnm ) and its impressive.


@PowerfulMedical secures €40M funding through @EU_Commission's #Tech4Cure initiative to scale #PMcardio, our AI that’s already helped detect 36,000+ heart attacks & save 1,000+ lives in just H1 2025! For more information, read the full press release: powerfulmedical.com/blog/pow…

🖥️ 📲 #PMcardio for Organizations just got even better with new analytics, outcome tracking, enhanced digitization, & 5x faster AI explainability—streamlining #STEMI care coordination & diagnostics. 🔗 Read about what's new in our latest #ProductUpdate: eu1.hubs.ly/H0h0L2h0

📢 Excited to attend the 44th Congress of the Belgian Society of Cardiology on 6–7 Feb. at Brussels Expo!🇧🇪 Meet us at Booth 34 to discover #PMcardio, our cardiac diagnostics & care coordination platform. We look forward to reconnect with partners & explore new collaborations.💙

📍 At #AHA2024, Dr @Sarajdiaz1 from @MountSinaiNYC presented external validation of #PMcardio titled “Enhancing Detection of Occlusive Myocardial Infarction: AI Model Versus Traditional STEMI Criteria." 💡 Find out more about her presentation in our blog: powerfulmedical.com/blog/pmc…

❤️ We’re deeply honored to be the 1st company ever to win both the Best Overall and Best Science Pitch awards at the AHA Health Tech Competition. Incredibly grateful to @American_Heart Association, @NancyatHeart, @StarJonesEsq & the esteemed panel of judges for the recognition.

Powerful Medical wins Best Overall and Best Science Pitch at the #AHA2024 Health Tech Competition! Thank you for this wonderful recognition @American_Heart.

50s M with acute chest pain. See the traditional computer algorithm’s interpretation!